Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or about $10.8 billion. Read More...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties
Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences Inc. for $200 a share, or about $10.8 billion. Read More...
Purchasing a home — especially in this market — can seem like a daunting task. Read More...
'A 5% interest rate is not going to break the market,' says Ben Snider, managing director, U.S. portfolio strategy at Goldman Sachs Asset Management. Read More...
The veteran musician has launched a 'wine seltzer' brand called Jetway, but that's not his only solo project.
Read More...
A study in the British Medical Journal says many infant formulas that say they'll help develop a baby's brain, eyes or nervous system aren't substantiated...
Exclusive: The famed composer behind Broadway's longest-running show tells MarketWatch it needs to 'just rest for a little bit.' Read More...
Netflix, Tesla, banks and credit-card companies report in the week ahead. Read More...
‘This is far from normal’: Bank failures have triggered a cash stampede into money funds, but there are complex trade-offs to consider.
Read More...
Rising income inequality undermines program’s ability to pay future retirement benefits, experts say
Read More...
India has overwhelming economic potential due to its population size and demographic makeup. The question is, will the country make the most of it?
Read More...